No. 24-6678
Omari Howard Patton v. United States
Response WaivedIFP
Tags: criminal-procedure drug-quantity extrapolation leadership-enhancement sentencing-guidelines uncharged-participants
Latest Conference:
2025-04-17
Question Presented (AI Summary)
Whether a leadership enhancement under U.S. Sentencing Guidelines 3B1.1(a) is permissible when drug quantity is extrapolated without chemist testimony and involves uncharged participants
Question Presented (OCR Extract)
■ WHEN FEDERAL defendants are ' BASED ON EXTRAPOLATION AND AS TO HOW THE EXTRAPOLATION EVIDENCE IN THE RECORD DOESATTRIBUTED A DRUG QUANTITY THE CHEMIST FAILS TO TESTIFYWAS CONDUCTED AND THERES NO THIS REQUIRE REVERSAL WHEN DEFENDANTS RECEIVE AN LEADERSHIP ENHANCEMENT UNDER 3B1.1(A) WHICH INVOLVED 5 OR MORE PARTICIPANTS NOT CHARGED IN THE INSTANT INDICTMENT BUT ARE INDICTMENT IS THE ENHANCEMENT PERMISSIBLEBUT THE 5 PARTICIPANTS ARE CHARGED IN A SEPARATE
Docket Entries
2025-04-21
Petition DENIED.
2025-03-27
DISTRIBUTED for Conference of 4/17/2025.
2025-03-20
Waiver of right of respondent United States to respond filed.
2025-02-11
Petition for a writ of certiorari and motion for leave to proceed in forma pauperis filed. (Response due March 31, 2025)
Attorneys
United States
D. John Sauer — Solicitor General, Respondent
D. John Sauer — Solicitor General, Respondent
Sarah M. Harris — Acting Solicitor General, Respondent